UNITE4TB partnership launches
15 Jul 2021
A new group has launched to move forward anti-tuberculosis science and treatment. The group has 30 partners from 13 countries. The group will look to progress new, safe and affordable treatments. The €185 million project, called UNITE4TB, will last for seven years. UNITE4TB will look at both existing and new drugs. The goal of UNITE4TB is to develop new and better treatment combinations for drug-resistant and -sensitive TB.